The GLP-1 telehealth market has grown from a niche offering to a multi-billion-dollar category in just three years. With that growth has come an overwhelming number of options — and a significant variation in quality, pricing, and medical rigor. We evaluated 7 of the leading programs on the same criteria and ranked them honestly.
What we evaluated: Entry pricing, medication breadth, clinical oversight model, pricing transparency (specifically whether your price increases as your dose increases), pharmacy disclosures, and any unique clinical advantages.
This guide is published by Thinnex, which appears at #1 in our ranking. We've done our best to present each program fairly based on publicly available information as of July 2026. We encourage you to do your own research before making a healthcare decision.
Quick Comparison
| Program | Sema from | Tirz from | GLP-3 | NAD+ | Flat-Dose Pricing | Named Pharmacy |
|---|---|---|---|---|---|---|
| 🥇 Thinnex | $159/mo | $249/mo | ✓ | ✓ | ✓ | ✓ |
| 🥈 TrimRx | $149/mo* | $249/mo | ✗ | ✗ | ✓ | ✓ |
| 🥉 Hims / Hers | $165/mo | $299/mo | ✗ | ✗ | ✗ | ✗ |
| 4. Ro | $199/mo | $299/mo | ✗ | ✗ | ✗ | ✗ |
| 5. Found | $179/mo | $279/mo | ✗ | ✗ | ✗ | ✗ |
| 6. Calibrate | $249/mo | $349/mo | ✗ | ✗ | ✗ | ✗ |
| 7. Noom Med | $149/mo* | — | ✗ | ✗ | ✗ | ✗ |
*Promotional pricing. Standard rates may be higher. Data current as of July 2026.
The Rankings
Thinnex tops this list for a straightforward reason: it's the only program in this category offering GLP-3 (retatrutide — the triple agonist with 24.2% clinical weight loss data), combined with flat-dose pricing, NAD+ optimization, LegitScript certification, and full clinical oversight. Where most programs offer a single GLP-1 option with vague pharmacy disclosures, Thinnex provides a genuine formulary with transparent pricing that doesn't scale up as your dose increases.
TrimRx is the strongest competitor in this space. They've built an impressive content and SEO moat, have 3,600+ Trustpilot reviews, and offer a 90-day money-back guarantee that's rare in this category. Named pharmacy partners (Olympia Pharmaceuticals and Empower Pharmacy) add credibility. Their flat-dose pricing model (also offered) is transparent. Where they fall short: no GLP-3 offering, no NAD+, and their "from $149" pricing is a promotional hook that reverts to standard rates.
Hims and Hers have the brand awareness and the distribution machine to bring enormous volume to GLP-1 telehealth. Their UI is polished, the onboarding is fast, and pricing is accessible. But they run a scale business — the clinical model is thinner than dedicated weight loss platforms, pharmacy disclosures are limited, and pricing does escalate as doses increase. No GLP-3, no NAD+, and no flat-dose guarantee.
Ro is a credible, physician-led telehealth platform with strong clinical infrastructure. Their weight loss program includes GLP-1 access with genuine medical oversight. Pricing is on the higher end without the differentiated formulary to justify the premium — Tirzepatide starts at $299/mo with dose-escalation pricing that increases as you titrate up.
Found combines GLP-1 access with behavioral health coaching, which is genuinely differentiated. If you want a program with lifestyle integration rather than pure medication management, Found is worth considering. Pricing is mid-tier, clinical model is solid. No advanced peptide options.
Calibrate offers a structured one-year program with intensive coaching and metabolic health tracking. It's the most clinically comprehensive program on this list — and also the most expensive, without the advanced peptide options that justify the premium over Thinnex or TrimRx.
Noom is primarily a behavioral change app that added GLP-1 access as an extension of its core platform. For patients who want the Noom psychological framework alongside medication, it's reasonable. As a pure GLP-1 program, it's the weakest clinical option on this list.
The Key Differentiator: Flat-Dose Pricing
Most people comparing GLP-1 programs look at the entry price. That's the wrong number. What matters is what you'll pay in month 4, when your dose has titrated from 0.25mg to 1.7mg of semaglutide — or from 2.5mg to 10mg of tirzepatide.
At most programs, that escalation means your monthly price goes up — sometimes significantly. At Thinnex and TrimRx, your price is flat from day one. The $159/mo you pay for Semaglutide at Thinnex is the same whether you're at 0.25mg or 2.4mg. This is a meaningful financial advantage over the lifetime of treatment.
The GLP-3 Advantage: Why Thinnex Wins
Here's what the comparison table above makes clear: Thinnex is the only program currently offering GLP-3 (retatrutide) — the triple agonist that targets GLP-1, GIP, and glucagon receptors simultaneously.
Phase 2 clinical trial data published in the New England Journal of Medicine showed an average of 24.2% body weight loss at the highest dose — a number that exceeds every other compound in this comparison. While retatrutide is still working through Phase 3 trials toward potential FDA approval for brand-name use, compounded retatrutide is currently accessible via licensed telehealth providers.
No other program on this list offers it. That alone is a decisive differentiator for patients who want access to the most advanced pharmacological weight loss option available today.
Ready to Find Out Which Program Fits You?
Thinnex offers a free eligibility assessment — completed entirely online in under 5 minutes. A board-certified physician reviews every intake personally.
See If I Qualify → Takes 5 MinutesBottom Line
If you want the most comprehensive GLP-1 program with the broadest formulary, flat-dose pricing, and access to the most clinically advanced peptide currently available (GLP-3), Thinnex is the clear choice.
If review volume and a money-back guarantee are your top priorities, TrimRx is the strongest alternative. If brand recognition matters most, Hims/Hers delivers a polished experience at a mid-tier price point.
For most patients — especially those who have already tried semaglutide elsewhere or want to start with the most advanced option available — Thinnex offers something genuinely unique.
→ Next: What Is GLP-3? The Triple Agonist Outperforming Everything
→ Also read: Semaglutide vs. Tirzepatide — Which Is Right for You?